NUTRA PHARMA CORP

Item 5.01. Changes in Control of Registrant. On August 21, 2026, Rik Deitsch transferred twelve million (12,000,000) shares of the Company’s Series B Preferred Stock to Pure Raw Supplies, LLC as a gift and for no consideration. Pursuant to the Certificate of Designation of the Series B Preferred Stock, the shares possess supermajority voting rights that provide the holder with voting power sufficient to control the outcome of substantially all matters submitted to the Company’s stockholders for approval. As a result of the transfer of the Series B Preferred Stock, a change in control of the Company occurred on August 21, 2026, and Pure Raw Supplies, LLC became the controlling stockholder of the Company. Immediately following the transfer, Pure Raw Supplies, LLC, through ownership of the Series B Preferred Stock, possessed 62.63% of the total voting power of the Company’s outstanding capital stock. Prior to the transfer, such voting power was held by Rik Deitsch. No consideration was paid in connection with the transfer.